BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25647013)

  • 1. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.
    Liotta F; Querci V; Mannelli G; Santarlasci V; Maggi L; Capone M; Rossi MC; Mazzoni A; Cosmi L; Romagnani S; Maggi E; Gallo O; Annunziato F
    Br J Cancer; 2015 Feb; 112(4):745-54. PubMed ID: 25647013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
    Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
    Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-Derived Mesenchymal Stem Cells do not Affect the Invasion and Migration Potential of Oral Squamous Carcinoma Cells.
    Sinha S; Narjus-Sterba M; Tuomainen K; Kaur S; Seppänen-Kaijansinkko R; Salo T; Mannerström B; Al-Samadi A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma.
    De Boeck A; Narine K; De Neve W; Mareel M; Bracke M; De Wever O
    Oral Oncol; 2010 May; 46(5):336-42. PubMed ID: 20219413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.
    Böhrnsen F; Fricke M; Sander C; Leha A; Schliephake H; Kramer FJ
    Clin Oral Investig; 2015 Jun; 19(5):1121-8. PubMed ID: 25346374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma.
    Rühle A; Lies M; Strack M; Perez RL; Bieber B; Thomsen AR; Bronsert P; Huber PE; Hess J; Knopf A; Wuchter P; Grosu AL; Nicolay NH
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.
    Kansy BA; Dißmann PA; Hemeda H; Bruderek K; Westerkamp AM; Jagalski V; Schuler P; Kansy K; Lang S; Dumitru CA; Brandau S
    Stem Cell Res Ther; 2014 Aug; 5(4):95. PubMed ID: 25115189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
    Krueger TE; Thorek DLJ; Meeker AK; Isaacs JT; Brennen WN
    Prostate; 2019 Feb; 79(3):320-330. PubMed ID: 30488530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
    Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.
    de Miranda MC; Melo MIA; Cunha PDS; Gentilini J; Faria JAQA; Rodrigues MA; Gomes DA
    Biomed Pharmacother; 2021 Dec; 144():112269. PubMed ID: 34794230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
    Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
    PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
    Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
    Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
    Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
    J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.